Literature DB >> 2673085

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies.

T E Starzl1, S Todo, A Tzakis, L Podesta, L Mieles, A Demetris, L Teperman, R Selby, W Stevenson, A Stieber.   

Abstract

Ten patients with primary malignant tumors of the biliary tract, duodenum, or stomach and with secondary involvement of the liver underwent removal of most or all of the stomach, liver, pancreas, spleen, duodenum, proximal jejunum, terminal ileum, and ascending and transverse colon. The void in the upper abdomen was filled with an organ cluster graft consisting of the liver, pancreas, duodenum, and variable segments of proximal jejunum. Eight of the ten patients are alive after 3 to 9 months, all with good liver and pancreas function, and most with satisfactory function of the gastrointestinal tract. One of the surviving patients was in the hospital for 4 months because of multiple enteric fistulas and infections; the other seven survivors were discharged after an average of 43 +/- 17.61 (SD) days. Recurrent tumor has not been proved in any of the surviving recipients and is suspected in only one. The study of such cases should provide insight and guidelines applicable to other visceral transplantation procedures that may be attempted in the future.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2673085      PMCID: PMC1358006          DOI: 10.1097/00000658-198909000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  Homotransplantation of multiple visceral organs.

Authors:  T E STARZL; H A KAUPP; D R BROCK; G W BUTZ; J W LINMAN
Journal:  Am J Surg       Date:  1962-02       Impact factor: 2.565

2.  Effect of a cyclic hexapeptide analog (L363,586) of somatostatin on the function of pancreas grafts in dogs.

Authors:  T Liu; D E Sutherland; P L Chinn; J S Najarian
Journal:  J Surg Res       Date:  1985-07       Impact factor: 2.192

3.  Transplantation of multiple abdominal viscera.

Authors:  T E Starzl; M I Rowe; S Todo; R Jaffe; A Tzakis; A L Hoffman; C Esquivel; K A Porter; R Venkataramanan; L Makowka
Journal:  JAMA       Date:  1989-03-10       Impact factor: 56.272

Review 4.  Hepatotrophic substances.

Authors:  T E Starzl; J Terblanche
Journal:  Prog Liver Dis       Date:  1979

5.  Effect of somatostatin analogue (SMS201-995) on cyclosporine levels.

Authors:  R Landgraf; M M Landgraf-Leurs; J Nusser; G Hillebrand; W D Illner; D Abendroth; W Land
Journal:  Transplantation       Date:  1987-11       Impact factor: 4.939

6.  Administration of somatostatin analog (SMS 201-995) in the treatment of a fistula occurring after pancreas transplantation. Interference with cyclosporine immunosuppression.

Authors:  L Rosenberg; D C Dafoe; R Schwartz; D A Campbell; J G Turcotte; S T Tsai; A Vinik
Journal:  Transplantation       Date:  1987-05       Impact factor: 4.939

7.  Splanchnic transplantation. An approach to the infant dependent on parenteral nutrition who develops irreversible liver disease.

Authors:  J W Williams; H N Sankary; P F Foster; J M Loew; G M Goldman; J Lowe
Journal:  JAMA       Date:  1989-03-10       Impact factor: 56.272

8.  Role of liver transplantation in cancer therapy.

Authors:  S Iwatsuki; R D Gordon; B W Shaw; T E Starzl
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

9.  The Eck fistula in animals and humans.

Authors:  T E Starzl; K A Porter; A Francavilla
Journal:  Curr Probl Surg       Date:  1983-11       Impact factor: 1.909

10.  Studies in small bowel transplantation. Prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum.

Authors:  D Shaffer; T Maki; S J DeMichele; M D Karlstad; B R Bistrian; K Balogh; A P Monaco
Journal:  Transplantation       Date:  1988-02       Impact factor: 4.939

View more
  59 in total

1.  Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts.

Authors:  N Murase; A J Demetris; D G Kim; S Todo; J J Fung; T E Starzl
Journal:  Surgery       Date:  1990-11       Impact factor: 3.982

2.  Inhibition of liver, kidney, and intestine regeneration by rapamycin.

Authors:  A Francavilla; T E Starzl; C Scotti; G Carrieri; A Azzarone; Q H Zeng; K A Porter; S L Schreiber
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

3.  Initial hepatic metabolic function in canine liver and pancreas cluster transplantation.

Authors:  M Hisanaga; Y Nakajima; M Segawa; M Matsumoto; T Fukuoka; H Yabuuchi; K Kido; M Horikawa; J Taki; A Yoshimura
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

4.  Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases.

Authors:  P B Carroll; C Ricordi; H R Rilo; P Fontes; R Khan; A G Tzakis; R Shapiro; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

5.  Glucose homeostasis is regulated by donor islets in xenografts.

Authors:  P B Carroll; Y Zeng; R Alejandro; T E Starzl; C Ricordi
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

Review 6.  [Liver transplantation for hilar cholangiocarcinoma].

Authors:  F Rauchfuss; F Utess; S Schüle; Y Dittmar; H Scheuerlein; U Settmacher
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

Review 7.  Themes of liver transplantation.

Authors:  Thomas E Starzl; John J Fung
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

8.  Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.

Authors:  A D Pinna; S Iwatsuki; R G Lee; S Todo; J R Madariaga; J W Marsh; A Casavilla; I Dvorchik; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

9.  Human islet allotransplantation under FK 506.

Authors:  C Ricordi; A Tzakis; P Carroll; Y Zeng; H L Rilo; R Alejandro; R Shapiro; J J Fung; D H Mintz; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

10.  Effect of FK 506 on function of human islets of Langerhans.

Authors:  H L Rilo; Y Zeng; R Alejandro; P B Carroll; D Bereiter; R Venkataramanan; A G Tzakis; T E Starzl; C Ricordi
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.